Results 251 to 260 of about 2,140,385 (376)
TGF‐β has a complex role in cancer, exhibiting both tumor‐suppressive and tumor‐promoting properties. Using a series of differentiated tumoroids, derived from different stages and mutational background of colorectal cancer patients, we replicate this duality of TGF‐β in vitro. Notably, the atypical but highly aggressive KRASQ22K mutation rendered early‐
Theresia Mair+17 more
wiley +1 more source
Genetic and Metabolic Disease in Paediatrics [PDF]
Lindsey I. Sinclair
openalex +1 more source
The implementation of genome sequencing in rare genetic diseases diagnosis: a pilot study from the Hong Kong genome project. [PDF]
Lam WKJ+38 more
europepmc +1 more source
Loss of the frequently mutated chromatin remodeler ARID1A, a subunit of the SWI/SNF cBAF complex, results in less open chromatin, alternative splicing, and the failure to stop cells from progressing through the cell cycle after DNA damage in bladder (cancer) cells. Created in BioRender. Epigenetic regulators, such as the SWI/SNF complex, with important
Rebecca M. Schlösser+11 more
wiley +1 more source
Genetic engineering and foot and mouth disease vaccines [PDF]
J. B. Brooksby
openalex +1 more source
Oral Problems in Brazilian Individuals with Rare Genetic Diseases That Affect Skeletal Development. [PDF]
Rabello F+6 more
europepmc +1 more source
Therapeutics in paediatric genetic diseases: Current and future landscape. [PDF]
Koh AL, Jamuar SS.
europepmc +1 more source
Germline variants in CDKN2A wild‐type melanoma prone families
Among melanoma‐prone families, wild‐type for CDKN2A and CDK4, some have pathogenic variants in genes not usually linked to melanoma. Furthermore, rare XP‐related variants and variants in MC1R are enriched in such families. Germline pathogenic variants in CDKN2A are well established as an underlying cause of familial malignant melanoma. While pathogenic
Gjertrud T. Iversen+5 more
wiley +1 more source